Abstract:Background: Adenomyosis is a commonly observed benign gynecological disease that affects the quality of life and social psychology of women of childbearing age. However, because of the unknown etiology and incidence of adenomyosis, its pathophysiological mechanism remains unclear; further, because no noninvasive, accurate, and individualized diagnostic methods are available, treatment and efficacy evaluations are limited. Notably, the interaction between the changes in the microecological environment of the female reproductive tract and human immunity, endocrine, and other links leads to the occurrence and development of diseases. In addition, the vaginal microbiome differs in different menstrual cycles; therefore, assessing the differences between the microbiomes of patients with adenomyosis and healthy individuals in different menstrual cycles will improve the understanding of the disease and provide references for the search for noninvasive diagnosis and individualized precision treatment of adenomyosis. This study aimed to explored the data of individuals in different menstrual cycles. Results: Differences in the vaginal microbiome between patients with adenomyosis and healthy individuals were observed. At phylum level, the relative abundance of Firmicutes in the adenomyosis group was higher than that in the control group, which contributed the most to the species difference between the two groups. At the genus level, Lactobacillus was the most dominant in both groups, Alpha-diversity analysis showed significant differences in the adenomyosis and control group during luteal phase (Shannon index, p = 0.0087; Simpson index, p = 0.0056). Beta-diversity index was significantly different between the two groups (p = 0.018). However, based on Weighted Unifrac analysis, significant differences were only observed throughout the luteal phase (p = 0.0146). Within the adenomyosis group, differences between women with different menstrual cycles were also observed. Finally, 50 possible biomarkers including were screened and predicted based on the random forest analyse. Conclusions: The vaginal microbiome of patients with adenomyosis and healthy individuals differed during menstrual periods, especially during the luteal phase. These findings facilitate the search for specific biological markers within a limited range and provide a more accurate, objective, and individualized diagnostic and therapeutic evaluation method for patients with adenomyosis, compared to what is currently available.

Differences in clinical characteristics for the determination of adenomyosis coexisting with leiomyomas

Clinical profiles of 710 premenopausal women with adenomyosis who underwent hysterectomy

Clinicopathologic characteristics of uterine adenomyoma in pregnant women.

Anemia-Associated Platelets and Plasma Prothrombin Time Increase in Patients with Adenomyosis.

Adenomyosis in women undergoing hysterectomy for abnormal uterine bleeding associated with uterine leiomyomas

Clinical Characteristics of Patients with Endometrial Cancer and Adenomyosis

Risk factors for adenomyosis in patients with symptomatic uterine leiomyomas.

Association Between Adenomyosis and Cervical Cancer: A Retrospective Cohort Study

Expression levels of genes involved in lipogenesis and cholesterol synthesis in adenomyosis

Differences in the incidence of obstetric complications depending on the extent and location of adenomyosis lesions

Frequency of endometriosis and adenomyosis in patients with leiomyomas, gynecologic premalignant, and malignant neoplasias

Adenomyosis Localized in Both the Anterior and Posterior Myometrium Is Associated with Deep Rectal Endometriosis: A Retrospective Study

Dysmenorrhea in Patients with Adenomyosis: A Clinical and Demographic Study.

Vaginal microbiome differences between patients with adenomyosis with different menstrual cycles and healthy controls

Prognostic significance of co-existent adenomyosis on outcomes and tumor characteristics of endometrial cancer: A meta-analysis

The association between sonographic features and clinical symptoms of adenomyosis

Impact of adenomyosis on pregnancy outcomes: a retrospective consecutive cohort study

Adenomyosis is associated with specific proton nuclear magnetic resonance (1H-NMR) serum metabolic profiles

Cornual adenomyosis in Essure® device users and in patients hysterectomized for other causes: A retrospective cohort study

Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer

Perinatal Outcomes Were Associated with the Positional Relationship Between Placenta and Adenomyotic Lesion in Pregnant Patients with Adenomyosis